Summit Tx Capital, L.P. Liquidia Corp Transaction History
Summit Tx Capital, L.P.
- $2.32 Trillion
- Q2 2025
A detailed history of Summit Tx Capital, L.P. transactions in Liquidia Corp stock. As of the latest transaction made, Summit Tx Capital, L.P. holds 13,774 shares of LQDA stock, worth $308,675. This represents 0.01% of its overall portfolio holdings.
Number of Shares
13,774Holding current value
$308,675% of portfolio
0.01%Shares
1 transactions
Others Institutions Holding LQDA
# of Institutions
209Shares Held
47.5MCall Options Held
1.61MPut Options Held
1.15M-
Black Rock Inc. New York, NY4.24MShares$95 Million0.0% of portfolio
-
Farallon Capital Management LLC San Francisco, CA4.24MShares$95 Million0.24% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.59MShares$80.5 Million0.0% of portfolio
-
Findell Capital Management LLC New York, NY3MShares$67.2 Million18.2% of portfolio
-
Opaleye Management Inc. Boston, MA2.48MShares$55.5 Million7.37% of portfolio
About Liquidia Corp
- Ticker LQDA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 64,362,300
- Market Cap $1.44B
- Description
- Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension. It also distributes generic treprostinil inje...